A team of German and American researchers has added another piece to the puzzle of what causes Alzheimer disease. They have found that a protein called “spastin” plays a previously unsuspected role: spastin is able to cut off the supply lines inside nerve cells,…

The biologist Caghan Kizil is to be granted approximately 1.7 million Euros over the next five years to develop his projects at the Dresden site of the DZNE. An international panel of experts approved his application for a “Helmholtz Young Investigators Group”…

Professor Dirk Isbrandt has been appointed W3-Professor for Experimental Neurophysiology. His research focuses on the molecular causes and mechanisms leading to changes in brain activity in neurological diseases such as epilepsy and Parkinson’s disease. With…

Scientists of the Charité – Universitätsmedizin Berlin and the DZNE have managed to acquire new insights into the functioning of a region in the brain that normally is involved in spatial orientation, but is damaged by the Alzheimer’s disease. They investigated…

The German Alzheimer Association (Deutsche Alzheimer Gesellschaft e.V. Selbsthilfe Demenz, DAlzG) and the DZNE aim to develop joint information services for dementia patients and their families. As World Alzheimer’s Day approaches on September 21st, the two…

Prof. Adriano Aguzzi of the University of Zurich (Switzerland) and Prof. Charles Weissmann of the Scripps Research Institute Florida (USA) will be awarded the 2013 “Hartwig Piepenbrock-DZNE Prize” for outstanding research in the field of neurodegenerative…

Prof. Thomas Wolbers from the Magdeburg site of the DZNE has been awarded a “Starting Grant” from the European Research Council (ERC) and thus, the support of one of Europe’s most prestigious funding programs. He will receive around 1.3 million Euros for a…

4th DZNE/Gladstone Workshop 11-13 May 2014, Bonn, Germany Cell and Organ Interactions in the Pathogenesis of Neurodegenerative Diseases The Gladstone Institute of Neurological Disease (GIND) and DZNE co-organize an annual workshop addressing the latest…

The drug rapamycin is known to increase lifespan in mice. Whether rapamycin slows down aging, however, remains unclear. A team of researchers from the s DZNE has now found that rapamycin extends lifespan - but its impact on aging itself is limited. The…

In the current issue of Science Translational Medicine, Luís Maia and Stephan Kaeser from the Hertie Institute for Clinical Brain Research at the University of Tübingen and the German Center for Neurodegenerative Diseases report, together with colleagues from…